Alma, a medical and aesthetic solutions provider, has commercially launched its Alma Harmony and Alma IQ in the US market to advance personalisation in aesthetic treatments.

Alma Harmony is said to be a versatile multi-application aesthetic workstation.

On the other hand, Alma IQ has been described to be an intelligent skin analysis and consultation solution.

Alma Harmony is US Food and Drug Administration (FDA)-cleared for more than 135 indications. It is based on Alma’s multi-technology aesthetics workstation.

The system has upgrades like the company’s proprietary AFT intense pulsed lights, the long-pulsed Nd:YAG 1064nm laser, the ablative 2940nm laser, and the Q-switched 1064nm ClearLift Pro laser.  

Other key expansions to the Alma Harmony range are the non-ablative 1540nm ClearSkin Pro laser, which are said to be clinically validated to enhance skin texture by up to 50%.

The workstation also has the precise 530nm diode VascuPen, designed for detailed vascular procedures.

Alma IQ is a custom skin analysis system to transform the patient consultation process.

It incorporates intelligent technology with 10 light modes, capable of scanning multiple skin layers within 10 seconds.

The solution aims to elevate how healthcare providers inform patients about their skin condition and tailor treatment plans using Alma’s range of products and technologies.

Alma North America president Keith Adams said: “Investing in Harmony, which serves thousands of customers worldwide, and adapting this workstation to meet contemporary demands was a logical step.

“The strategic timing of the Alma IQ launch, synchronised with our multi-application aesthetic workstation, was meticulously planned.

“This approach ensures our future customers are well-equipped to maximise the utility of technologies offered in Alma Harmony and beyond.”

Alma serves both aesthetic and surgical fields. The company’s range of technologies includes laser, light-based radio frequency (RF), plasma, and ultrasound to administer safe, efficient, and life-changing treatments.